Cargando…
The Potential Prebiotic Berberine Combined With Methimazole Improved the Therapeutic Effect of Graves’ Disease Patients Through Regulating the Intestinal Microbiome
Graves’ disease, a typical metabolism disorder, causes diffuse goiter accompanied by ocular abnormalities and ocular dysfunction. Although methimazole (MI) is a commonly used drug for the treatment of GD, the efficacy of methimazole is only limited to the control of clinical indicators, and the side...
Autores principales: | Han, Zhe, Cen, Chaoping, Ou, Qianying, Pan, Yonggui, Zhang, Jiachao, Huo, Dongxue, Chen, Kaining |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785824/ https://www.ncbi.nlm.nih.gov/pubmed/35082799 http://dx.doi.org/10.3389/fimmu.2021.826067 |
Ejemplares similares
-
Probiotic Bifidobacterium longum supplied with methimazole improved the thyroid function of Graves’ disease patients through the gut-thyroid axis
por: Huo, Dongxue, et al.
Publicado: (2021) -
Compositional and genetic alterations in Graves’ disease gut microbiome reveal specific diagnostic biomarkers
por: Zhu, Qiyun, et al.
Publicado: (2021) -
Correction to: Compositional and genetic alterations in Graves’ disease gut microbiome reveal specific diagnostic biomarkers
por: Zhu, Qiyun, et al.
Publicado: (2022) -
Methimazole-Induced Pleural Effusion in the Setting of Graves' Disease
por: Khine, Le Yu, et al.
Publicado: (2019) -
Changes of IgG N-Glycosylation in Thyroid Autoimmunity: The Modulatory Effect of Methimazole in Graves’ Disease and the Association With the Severity of Inflammation in Hashimoto’s Thyroiditis
por: Trzos, Sara, et al.
Publicado: (2022)